Amit Rakhit leads the Development and Medical teams at BlueRock. He is an experienced pharmaceutical and biotech executive and has led teams in developing medicines across multiple therapeutic areas, including oncology, neurology, rare diseases, and cardiovascular conditions. Prior to joining BlueRock, Amit was CEO at Flare Therapeutics, where he transitioned the company from research to the clinical phase. He has also served as President and Chief Medical Officer at Ovid Therapeutics and held senior-level positions at Bristol-Myers Squibb and Biogen. Amit holds a BA in molecular cell biology from the University of California, Berkeley, an MD from Tufts University, and an MBA from the joint program between Columbia Business School and London Business School. He completed a Harvard fellowship training in Pediatric Cardiology at Boston Children’s Hospital.
